From: Construction and investigation of β3GNT2-associated regulatory network in esophageal carcinoma
Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value | ||
T stage (T3 and T4 vs. T1 and T2) | 145 | 1.312 (0.756–2.277) | 0.334 | ||
N stage (N1 and N2 and N3 vs. N0) | 144 | 2.970 (1.606–5.493) | < 0.001 | 2.173 (0.954–4.946) | 0.064 |
M stage (M1 vs. M0) | 129 | 5.075 (2.312–11.136) | < 0.001 | 2.515 (1.083–5.838) | 0.032 |
Gender (Male vs. Female) | 162 | 2.306 (0.922–5.770) | 0.074 | 1.957 (0.573–6.689) | 0.284 |
Age (> 60 vs. ≤ 60) | 162 | 0.831 (0.506–1.365) | 0.466 | ||
Pathologic stage (III and IV vs. I and II) | 142 | 3.223 (1.807–5.747) | < 0.001 | 1.788 (0.810–3.947) | 0.151 |
Histological type (Adenocarcinoma vs. squamous cell carcinoma) | 162 | 0.875 (0.526–1.455) | 0.607 | ||
β3GNT2 (High vs. low) | 162 | 1.736 (1.041–2.897) | 0.035 | 1.537 (0.839–2.815) | 0.043 |